Video

Dr. Coleman on Moving Immunotherapy Into Earlier Treatment Lines in Cervical Cancer

Robert L. Coleman, MD, FACOG, FACS, discusses the potential to move immunotherapy into earlier lines of treatment in cervical cancer.

Robert L. Coleman, MD, FACOG, FACS, chief scientific officer of The US Oncology Network, discusses the potential to move immunotherapy into earlier lines of treatment in cervical cancer.

The introduction of immunotherapy to the cervical cancer paradigm has been welcome as limited treatment options are available to these patients. Looking to ongoing research, the field hopes to sequence immunotherapy earlier into treatment, Coleman explains.

For example, the concept of utilizing immunotherapy plus radiation therapy followed by maintenance therapy could be beneficial in the adjuvant and localized disease settings, Coleman explains. Throughout 2021, it is likely that data regarding this approach will read out. Moreover, as the treatment landscape of cervical cancer has been relatively stagnant in recent years, the potential to offer a new treatment approach to patients with cervical cancer is exciting, Coleman concludes.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity